Skeletalis Bio
PrivateLast Round
Seed
Nov 17, 2025
Total Funding Raised
$8M
Company Overview
Skeletalis Bio is a biotechnology company developing a platform of targeted small-molecule therapeutics for treating osteoporosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Skeletalis Bio Comps
Public and private peers based on sector, stage, and business model.
Skeletalis Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 17, 2025 |
Skeletalis Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| age1 | Seed |
| Pillar VC | Seed |
| KdT Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 17, 2025
Raised $8M in a Seed round.
Skeletalis Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Skeletalis Bio's valuation, stock price, and market status.
